PURPOSE: Recent research and professional guidelines support expanded use of outpatient subspecialty palliative care in oncology, but provider referral practices vary widely. We sought to explore oncologist factors that influence referrals to outpatient palliative care. METHODS: Multisite, qualitative interview study at three academic cancer centers in the United States with well-established palliative care clinics. Seventy-four medical oncologists participated in semistructured interviews between February and October 2012. The interview guide asked about experiences and decision making regarding outpatient palliative care use. A multidisciplinary team analyzed interview transcripts using constant comparative methods to inductively develop and refine themes related to palliative care referral decisions. RESULTS: We identified three main oncologist barriers to subspecialty palliative care referrals at sites with comprehensive palliative care clinics: persistent conceptions of palliative care as an alternative philosophy of care incompatible with cancer therapy, a predominant belief that providing palliative care is an integral part of the oncologist's role, and a lack of knowledge about locally available services. Participants described their views of subspecialty palliative care as evolving in response to increasing availability of services and positive referral experiences, but emphasized that views of palliative care as valuable in addition to standard oncology care were not universally shared by oncologists. CONCLUSIONS: Improving provision of palliative care in oncology will likely require efforts beyond increasing service availability. Raising awareness of ways in which subspecialty palliative care complements standard oncology care and developing ways for oncologists and palliative care physicians to collaborate and integrate their respective skills may help.
PURPOSE: Recent research and professional guidelines support expanded use of outpatient subspecialty palliative care in oncology, but provider referral practices vary widely. We sought to explore oncologist factors that influence referrals to outpatient palliative care. METHODS: Multisite, qualitative interview study at three academic cancer centers in the United States with well-established palliative care clinics. Seventy-four medical oncologists participated in semistructured interviews between February and October 2012. The interview guide asked about experiences and decision making regarding outpatient palliative care use. A multidisciplinary team analyzed interview transcripts using constant comparative methods to inductively develop and refine themes related to palliative care referral decisions. RESULTS: We identified three main oncologist barriers to subspecialty palliative care referrals at sites with comprehensive palliative care clinics: persistent conceptions of palliative care as an alternative philosophy of care incompatible with cancer therapy, a predominant belief that providing palliative care is an integral part of the oncologist's role, and a lack of knowledge about locally available services. Participants described their views of subspecialty palliative care as evolving in response to increasing availability of services and positive referral experiences, but emphasized that views of palliative care as valuable in addition to standard oncology care were not universally shared by oncologists. CONCLUSIONS: Improving provision of palliative care in oncology will likely require efforts beyond increasing service availability. Raising awareness of ways in which subspecialty palliative care complements standard oncology care and developing ways for oncologists and palliative care physicians to collaborate and integrate their respective skills may help.
Authors: Michael H Levy; Anthony Back; Costantino Benedetti; J Andrew Billings; Susan Block; Barry Boston; Eduardo Bruera; Sydney Dy; Catherine Eberle; Kathleen M Foley; Sloan Beth Karver; Sara J Knight; Sumathi Misra; Christine S Ritchie; David Spiegel; Linda Sutton; Susan Urba; Jamie H Von Roenn; Sharon M Weinstein Journal: J Natl Compr Canc Netw Date: 2009-04 Impact factor: 11.908
Authors: David Hui; Ahmed Elsayem; Maxine De la Cruz; Ann Berger; Donna S Zhukovsky; Shana Palla; Avery Evans; Nada Fadul; J Lynn Palmer; Eduardo Bruera Journal: JAMA Date: 2010-03-17 Impact factor: 56.272
Authors: Marie Bakitas; Kathleen Doyle Lyons; Mark T Hegel; Stefan Balan; Frances C Brokaw; Janette Seville; Jay G Hull; Zhongze Li; Tor D Tosteson; Ira R Byock; Tim A Ahles Journal: JAMA Date: 2009-08-19 Impact factor: 56.272
Authors: Frank D Ferris; Eduardo Bruera; Nathan Cherny; Charmaine Cummings; David Currow; Deborah Dudgeon; Nora Janjan; Florian Strasser; Charles F von Gunten; Jamie H Von Roenn Journal: J Clin Oncol Date: 2009-05-18 Impact factor: 44.544
Authors: Yael Schenker; Nathan Bahary; Rene Claxton; Julie Childers; Edward Chu; Dio Kavalieratos; Linda King; Barry Lembersky; Greer Tiver; Robert M Arnold Journal: J Palliat Med Date: 2017-08-03 Impact factor: 2.947
Authors: Justin A Yu; Kristin N Ray; Seo Young Park; Amanda Barry; Cardinale B Smith; Peter G Ellis; Yael Schenker Journal: J Oncol Pract Date: 2018-11-08 Impact factor: 3.840
Authors: Anna Sorensen; Kirsten Wentlandt; Lisa W Le; Nadia Swami; Breffni Hannon; Gary Rodin; Monika K Krzyzanowska; Camilla Zimmermann Journal: Support Care Cancer Date: 2019-06-04 Impact factor: 3.603
Authors: David Hui; Masanori Mori; Yee-Choon Meng; Sharon M Watanabe; Augusto Caraceni; Florian Strasser; Tiina Saarto; Nathan Cherny; Paul Glare; Stein Kaasa; Eduardo Bruera Journal: Support Care Cancer Date: 2017-07-19 Impact factor: 3.603
Authors: Judith M Resick; Robert M Arnold; Rebecca L Sudore; David Farrell; Shane Belin; Andrew D Althouse; Betty Ferrell; Bernard J Hammes; Edward Chu; Douglas B White; Kimberly J Rak; Yael Schenker Journal: Contemp Clin Trials Date: 2020-07-31 Impact factor: 2.226